-
1
-
-
83555164893
-
Targeting chemokine receptors in chronic inflammatory disease: An extensive review
-
Koelink, P. J.; Overbeek, S. A.; Braber, S.; de Kruijf, P.; Folkerts, G.; Smit, M. J.; Kraneveld, A. D. Targeting chemokine receptors in chronic inflammatory disease: an extensive review Pharmacol. Ther. 2012, 133, 1-18
-
(2012)
Pharmacol. Ther.
, vol.133
, pp. 1-18
-
-
Koelink, P.J.1
Overbeek, S.A.2
Braber, S.3
De Kruijf, P.4
Folkerts, G.5
Smit, M.J.6
Kraneveld, A.D.7
-
2
-
-
84869994291
-
Chemikone Receptor Antagonists
-
Pease, J.; Horuk, R. Chemikone Receptor Antagonists J. Med. Chem. 2012, 55, 9363-9392
-
(2012)
J. Med. Chem.
, vol.55
, pp. 9363-9392
-
-
Pease, J.1
Horuk, R.2
-
3
-
-
0036485214
-
Chemokine receptors: Multifaceted therapeutic targets
-
Proudfoot, A. E. I. Chemokine receptors: multifaceted therapeutic targets Nature Rev. Immunol. 2002, 2, 106-115 (Pubitemid 37323234)
-
(2002)
Nature Reviews Immunology
, vol.2
, Issue.2
, pp. 106-115
-
-
Proudfoot, A.E.I.1
-
4
-
-
0031963014
-
Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
-
DOI 10.1084/jem.187.1.129
-
Bonecchi, R.; Bianchi, G.; Bordignon, P. P.; D'ambrosio, D.; Land, R.; Borsatti, A.; Sozzani, S.; Allavena, P.; Gray, P. A.; Mantovani, A.; Sinigaglia, F. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s J. Exp. Med. 1998, 187, 129-134 (Pubitemid 28044828)
-
(1998)
Journal of Experimental Medicine
, vol.187
, Issue.1
, pp. 129-134
-
-
Bonecchi, R.1
Bianchi, G.2
Bordignon, P.P.3
D'Ambrosio, D.4
Lang, R.5
Borsatti, A.6
Sozzani, S.7
Allavena, P.8
Gray, P.A.9
Mantovani, A.10
Sinigaglia, F.11
-
5
-
-
0034003308
-
Allergen immunotherapy: Current and new therapeutic strategies
-
Rolland, J. M.; Douglass, J.; O'Hehir, R. E. Allergen immunotherapy: current and new therapeutic strategies Expert Opin. Invest. Drugs 2000, 9, 515-527 (Pubitemid 30119690)
-
(2000)
Expert Opinion on Investigational Drugs
, vol.9
, Issue.3
, pp. 515-527
-
-
Rolland, J.M.1
Douglass, J.2
O'Hehir, R.E.3
-
6
-
-
0034988909
-
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics
-
Panina-Bordignon, P.; Papi, A.; Mariani, M.; Lucia, P. D.; Casoni, G.; Bellettato, C.; Buonsanti, C.; Miotto, D.; Mapp, C.; Villa, A.; Arrigoni, G.; Fabri, L. M.; Sinigaglia, F. The CC chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics J. Clin. Invest. 2001, 107, 1357-1364 (Pubitemid 32522029)
-
(2001)
Journal of Clinical Investigation
, vol.107
, Issue.11
, pp. 1357-1364
-
-
Panina-Bordignon, P.1
Papi, A.2
Mariani, M.3
Di Lucia, P.4
Casoni, G.5
Bellettato, C.6
Buonsanti, C.7
Miotto, D.8
Mapp, C.9
Villa, A.10
Arrigoni, G.11
Fabbri, L.M.12
Sinigaglia, F.13
-
7
-
-
77952783111
-
Chemokine receptor 4 plays a key role in T cell recruitment into the airways of asthmatic patients
-
Vijayanand, P.; Durkin, K.; Hartmann, G.; Morjaria, J.; Seumois, G.; Staples, K. J.; Hall, D.; Bessant, C.; Bartholomew, M.; Howarth, P. H.; Friedmann, P. S.; Djukanović, R. Chemokine receptor 4 plays a key role in T cell recruitment into the airways of asthmatic patients J. Immunol. 2010, 184, 4568-4574
-
(2010)
J. Immunol.
, vol.184
, pp. 4568-4574
-
-
Vijayanand, P.1
Durkin, K.2
Hartmann, G.3
Morjaria, J.4
Seumois, G.5
Staples, K.J.6
Hall, D.7
Bessant, C.8
Bartholomew, M.9
Howarth, P.H.10
Friedmann, P.S.11
Djukanović, R.12
-
8
-
-
81155123829
-
The pathology and immunology of atopic dermatitis
-
Rahman, S.; Collins, M.; Williams, C. M. M.; Ma, H.-L. The pathology and immunology of atopic dermatitis Inflammation Allergy: Drug Targets 2011, 10, 486-496
-
(2011)
Inflammation Allergy: Drug Targets
, vol.10
, pp. 486-496
-
-
Rahman, S.1
Collins, M.2
Williams, C.M.M.3
Ma, H.-L.4
-
9
-
-
33845601159
-
Chemokines in allergic aspergillosis - From animal models to human lung diseases
-
Hartl, D.; Buckland, K. F.; Hogaboam, C. M. Chemokines in allergic aspergillosis-from animal to human lung disease Inflammation Allergy: Drug Targets 2006, 5, 219-228 (Pubitemid 44941932)
-
(2006)
Inflammation and Allergy - Drug Targets
, vol.5
, Issue.4
, pp. 219-228
-
-
Hartl, D.1
Buckland, K.F.2
Hogaboam, C.M.3
-
10
-
-
84355162957
-
Antibody therapy for adult T-cell leukemia-lymphoma
-
Ishida, T.; Ueda, R. Antibody therapy for adult T-cell leukemia-lymphoma Int. J. Hematol. 2011, 94, 443-452
-
(2011)
Int. J. Hematol.
, vol.94
, pp. 443-452
-
-
Ishida, T.1
Ueda, R.2
-
11
-
-
78650843385
-
Role of the chemokine receptors CCR1, CCR2 and CCR4 in the pathogenesis of experimental dengue infection in mice
-
Guabiraba, R.; Marques, R. E.; Besnard, A.-G.; Fagundes, C. T.; Souza, D. G.; Ryffel, B.; Teixeira, M. M. Role of the chemokine receptors CCR1, CCR2 and CCR4 in the pathogenesis of experimental dengue infection in mice PLoS One 2010, 5 (12) e15680
-
(2010)
PLoS One
, vol.5
, Issue.12
, pp. 15680
-
-
Guabiraba, R.1
Marques, R.E.2
Besnard, A.-G.3
Fagundes, C.T.4
Souza, D.G.5
Ryffel, B.6
Teixeira, M.M.7
-
12
-
-
77955330984
-
CC Chemokine Receptor 4 (CCR4) in human allergen-induced late nasal responses
-
Banfield, G.; Watanabe, H.; Scadding, G.; Jacobson, M. R.; Till, S. J.; Hall, D. A.; Robinson, D. S.; Lloyd, C. M.; Nouri-Aria, K. T.; Durham, S. R. CC Chemokine Receptor 4 (CCR4) in human allergen-induced late nasal responses Allergy 2010, 65, 1126-1133
-
(2010)
Allergy
, vol.65
, pp. 1126-1133
-
-
Banfield, G.1
Watanabe, H.2
Scadding, G.3
Jacobson, M.R.4
Till, S.J.5
Hall, D.A.6
Robinson, D.S.7
Lloyd, C.M.8
Nouri-Aria, K.T.9
Durham, S.R.10
-
14
-
-
33645893175
-
Optimization of 2-aminothiazole derivatives as CCR4 antagonists
-
Wang, X.; Xu, F.; Xu, Q.; Mahmud, H.; Houze, J.; Zhu, L.; Akerman, M.; Tonn, G.; Tang, L.; McMaster, B. E.; Dairaghi, D. J.; Schall, T. J.; Collins, T. L.; Medina, J. C. Optimization of 2-aminothiazole derivatives as CCR4 antagonists Bioorg. Med. Chem. Lett. 2006, 16, 2800-2803
-
(2006)
Bioorg. Med. Chem. Lett.
, vol.16
, pp. 2800-2803
-
-
Wang, X.1
Xu, F.2
Xu, Q.3
Mahmud, H.4
Houze, J.5
Zhu, L.6
Akerman, M.7
Tonn, G.8
Tang, L.9
McMaster, B.E.10
Dairaghi, D.J.11
Schall, T.J.12
Collins, T.L.13
Medina, J.C.14
-
15
-
-
33846202995
-
Core exploration in optimization of chemokine receptor CCR4 antagonists
-
DOI 10.1016/j.bmcl.2006.10.091, PII S0960894X06012807
-
Purandare, A. V.; Wan, H.; Somerville, J. E.; Burke, C.; Vaccaro, W.; Yang, X.; McIntyre, K. W.; Poss, M. A. Core exploration in optimization of chemokine receptor CCR4 antagonists Bioorg. Med. Chem. Lett. 2007, 17, 679-682 (Pubitemid 46108567)
-
(2007)
Bioorganic and Medicinal Chemistry Letters
, vol.17
, Issue.3
, pp. 679-682
-
-
Purandare, A.V.1
Wan, H.2
Somerville, J.E.3
Burke, C.4
Vaccaro, W.5
Yang, X.6
McIntyre, K.W.7
Poss, M.A.8
-
16
-
-
34548155743
-
Bipiperidinyl carboxylic acid amides as potent, selective, and functionally active CCR4 antagonists
-
DOI 10.1111/j.1747-0285.2007.00551.x
-
Kuhn, C. F.; Bazin, M.; Philippe, L.; Zhang, J.; Tylaska, L.; Miret, J.; Bauer, P. H. Bipiperidinyl carboxylic acid amides as potent, selective, and functionally active CCR4 antagonists Chem. Biol. Drug Des. 2007, 70, 268-272 (Pubitemid 47305399)
-
(2007)
Chemical Biology and Drug Design
, vol.70
, Issue.3
, pp. 268-272
-
-
Kuhn, C.F.1
Bazin, M.2
Philippe, L.3
Zhang, J.4
Tylaska, L.5
Miret, J.6
Bauer, P.H.7
-
17
-
-
34247876125
-
Small molecule antagonists of the CC chemokine receptor 4 (CCR4)
-
DOI 10.1016/j.bmcl.2007.03.030, PII S0960894X07003228
-
Burdi, D. F.; Chi, S.; Mattia, K.; Harrington, C.; Shi, Z.; Chen, S.; Jacutin-Porte, S.; Bennett, R.; Carson, K.; Yin, W.; Kansra, V.; Gonzalo, J.-A.; Coyle, A.; Jaffee, B.; Ocain, T.; Hodge, M.; LaRosa, G.; Harriman, G. Small molecule antagonists of the CC chemokine receptor 4 (CCR4) Bioorg. Med. Chem. Lett. 2007, 17, 3141-3145 (Pubitemid 46702615)
-
(2007)
Bioorganic and Medicinal Chemistry Letters
, vol.17
, Issue.11
, pp. 3141-3145
-
-
Burdi, D.F.1
Chi, S.2
Mattia, K.3
Harrington, C.4
Shi, Z.5
Chen, S.6
Jacutin-Porte, S.7
Bennett, R.8
Carson, K.9
Yin, W.10
Kansra, V.11
Gonzalo, J.-A.12
Coyle, A.13
Jaffee, B.14
Ocain, T.15
Hodge, M.16
LaRosa, G.17
Harriman, G.18
-
18
-
-
50349100768
-
Potent CCR4 antagonists: Synthesis, evaluation and docking study of 2,4-diaminoquinazolines
-
Yokoyama, K.; Ishikawa, N.; Igarashi, S.; Kawano, N.; Masuda, N.; Hattori, K.; Miyazaki, T.; Ogino, S.-I.; Orita, M.; Matsumoto, Y.; Takeuchi, M.; Ohta, M. Potent CCR4 antagonists: synthesis, evaluation and docking study of 2,4-diaminoquinazolines Bioorg. Med. Chem. 2008, 16, 7968-7974
-
(2008)
Bioorg. Med. Chem.
, vol.16
, pp. 7968-7974
-
-
Yokoyama, K.1
Ishikawa, N.2
Igarashi, S.3
Kawano, N.4
Masuda, N.5
Hattori, K.6
Miyazaki, T.7
Ogino, S.-I.8
Orita, M.9
Matsumoto, Y.10
Takeuchi, M.11
Ohta, M.12
-
19
-
-
70350738223
-
Novel CC chemokine receptor 4 antagonist RS-1154 inhibits ovalbumin-induced ear swelling in mice
-
Nakagami, Y.; Kawashima, K.; Yonekubo, K.; Etori, M.; Jojima, T.; Miyazaki, S.; Sawamura, R.; Hirahara, K.; Nara, F.; Yamashita, M. Novel CC chemokine receptor 4 antagonist RS-1154 inhibits ovalbumin-induced ear swelling in mice Eur. J. Pharmacol. 2009, 624, 38-44
-
(2009)
Eur. J. Pharmacol.
, vol.624
, pp. 38-44
-
-
Nakagami, Y.1
Kawashima, K.2
Yonekubo, K.3
Etori, M.4
Jojima, T.5
Miyazaki, S.6
Sawamura, R.7
Hirahara, K.8
Nara, F.9
Yamashita, M.10
-
20
-
-
57649229431
-
Potent and orally bioavailable CCR4 antagonists: Synthesis and structure-activity relationship study of 2-aminoquinazolines
-
Yokoyama, K.; Ishikawa, N.; Igarashi, S.; Kawano, N.; Masuda, N.; Hamaguchi, W.; Yamasaki, S.; Koganemaru, Y.; Hattori, K.; Miyazaki, T.; Miyazaki, T.; Ogino, S.-I.; Matsumoto, Y.; Takeuchi, M.; Ohta, M. Potent and orally bioavailable CCR4 antagonists: synthesis and structure-activity relationship study of 2-aminoquinazolines Bioorg. Med. Chem. 2009, 17, 64-73
-
(2009)
Bioorg. Med. Chem.
, vol.17
, pp. 64-73
-
-
Yokoyama, K.1
Ishikawa, N.2
Igarashi, S.3
Kawano, N.4
Masuda, N.5
Hamaguchi, W.6
Yamasaki, S.7
Koganemaru, Y.8
Hattori, K.9
Miyazaki, T.10
Miyazaki, T.11
Ogino, S.-I.12
Matsumoto, Y.13
Takeuchi, M.14
Ohta, M.15
-
21
-
-
59349088027
-
Synthesis of thiourea derivatives as CCR4 antagonists
-
Zhao, F.; Xiao, J.-H.; Wang, Y.; Li, S. Synthesis of thiourea derivatives as CCR4 antagonists Chin. Chem. Lett. 2009, 20, 296-299
-
(2009)
Chin. Chem. Lett.
, vol.20
, pp. 296-299
-
-
Zhao, F.1
Xiao, J.-H.2
Wang, Y.3
Li, S.4
-
22
-
-
77953365040
-
RS-1748, a novel CC chemokine receptor 4 antagonist, inhibits ovalbumin-induced airway inflammation in guinea pigs
-
Nakagami, Y.; Kawase, Y.; Yonekubo, K.; Nosaka, E.; Etori, M.; Takahashi, S.; Takagi, N.; Fukuda, T.; Kuribayashi, T.; Nara, F.; Yamashita, M. RS-1748, a novel CC chemokine receptor 4 antagonist, inhibits ovalbumin-induced airway inflammation in guinea pigs Biol. Pharm. Bull. 2010, 33, 1067-1069
-
(2010)
Biol. Pharm. Bull.
, vol.33
, pp. 1067-1069
-
-
Nakagami, Y.1
Kawase, Y.2
Yonekubo, K.3
Nosaka, E.4
Etori, M.5
Takahashi, S.6
Takagi, N.7
Fukuda, T.8
Kuribayashi, T.9
Nara, F.10
Yamashita, M.11
-
23
-
-
77956824364
-
A novel CC chemokine receptor 4 antagonist RS-1269 inhibits ovalbumin-induced ear swelling and lipopolysaccharide-induced endotoxic shock in mice
-
Nakagami, Y.; Kawashima, K.; Etori, M.; Yonekubo, K.; Suzuki, C.; Jojima, T.; Kuribayashi, T.; Nara, F.; Yamashita, M. A novel CC chemokine receptor 4 antagonist RS-1269 inhibits ovalbumin-induced ear swelling and lipopolysaccharide-induced endotoxic shock in mice Basic Clin. Pharmacol. Toxicol. 2010, 107, 793-797
-
(2010)
Basic Clin. Pharmacol. Toxicol.
, vol.107
, pp. 793-797
-
-
Nakagami, Y.1
Kawashima, K.2
Etori, M.3
Yonekubo, K.4
Suzuki, C.5
Jojima, T.6
Kuribayashi, T.7
Nara, F.8
Yamashita, M.9
-
24
-
-
70350706772
-
-
WO2003059893A1, 24 Jul.
-
Baxter, A.; Johnson, T.; Kindon, N.; Roberts, B.; Stocks, M. N -Pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases. WO2003059893A1, 24 Jul 2003.
-
(2003)
N -Pyrazinyl-phenylsulphonamides and Their Use in the Treatment of Chemokine Mediated Diseases
-
-
Baxter, A.1
Johnson, T.2
Kindon, N.3
Roberts, B.4
Stocks, M.5
-
25
-
-
84875202094
-
-
WO2004007472A1, 22 Jan.
-
Habashita, H.; Kokubo, M.; Shibayama, S.; Tada, H.; Sagawa, K. CCR4 antagonist and medicinal use thereof. WO2004007472A1, 22 Jan 2004.
-
(2004)
CCR4 Antagonist and Medicinal Use Thereof
-
-
Habashita, H.1
Kokubo, M.2
Shibayama, S.3
Tada, H.4
Sagawa, K.5
-
26
-
-
84859440608
-
Lead optimization of the N 1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation
-
Procopiou, P. A.; Ford, A. J.; Graves, R. H.; Hall, D. A.; Hodgson, S. T.; Lacroix, Y. M. L.; Needham, D.; Slack, R. J. Lead optimization of the N 1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation Bioorg. Med. Chem. Lett. 2012, 22, 2730-2733
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, pp. 2730-2733
-
-
Procopiou, P.A.1
Ford, A.J.2
Graves, R.H.3
Hall, D.A.4
Hodgson, S.T.5
Lacroix, Y.M.L.6
Needham, D.7
Slack, R.J.8
-
27
-
-
40849124250
-
An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5
-
DOI 10.1124/mol.107.039321
-
Andrews, G.; Jones, C.; Wreggett, K. A. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5 Mol. Pharmacol. 2008, 73, 855-867 (Pubitemid 351397890)
-
(2008)
Molecular Pharmacology
, vol.73
, Issue.3
, pp. 855-867
-
-
Andrews, G.1
Jones, C.2
Wreggett, K.A.3
-
29
-
-
0025037110
-
Novel 1,4-dihydropyridine calcium antagonists. I. Synthesis and hypotensive activity of 4-(substituted pyridyl)-1,4-dihydropyridine derivatives
-
Ashimori, A.; Ono, T.; Uchida, T.; Ohtaki, Y.; Fukaya, C.; Watanabe, M.; Yokoyama, K. Novel 1,4-dihydropyridine calcium antagonists. I. Synthesis and hypotensive activity of 4-(substituted pyridyl)-1,4-dihydropyridine derivatives Chem. Pharm. Bull. 1990, 38, 2446-2458 (Pubitemid 20357296)
-
(1990)
Chemical and Pharmaceutical Bulletin
, vol.38
, Issue.9
, pp. 2446-2458
-
-
Ashimori, A.1
Ono, T.2
Uchida, T.3
Ohtaki, Y.4
Fukaya, C.5
Watanabe, M.6
Yokoyama, K.7
-
30
-
-
84863224949
-
Development of Operational Models of Receptor Activation Including Constitutive Receptor Activity and their Use to Determine the Efficacy of the Chemokine CCL17 at the CC-Chemokine Receptor CCR4
-
Slack, R. J.; Hall, D. A. Development of Operational Models of Receptor Activation Including Constitutive Receptor Activity and their Use to Determine the Efficacy of the Chemokine CCL17 at the CC-Chemokine Receptor CCR4 Br. J. Pharmacol. 2012, 166, 1774-1792
-
(2012)
Br. J. Pharmacol.
, vol.166
, pp. 1774-1792
-
-
Slack, R.J.1
Hall, D.A.2
-
31
-
-
35748934487
-
The influence of drug-like concepts on decision-making in medicinal chemistry
-
DOI 10.1038/nrd2445, PII NRD2445
-
Leeson, P. D.; Springthorpe, B. The influence of drug-like concepts on decision making in medicinal chemistry Nature Rev. Drug Discovery 2007, 6, 881-890 (Pubitemid 350042396)
-
(2007)
Nature Reviews Drug Discovery
, vol.6
, Issue.11
, pp. 881-890
-
-
Leeson, P.D.1
Springthorpe, B.2
-
32
-
-
80051799265
-
Assessing the lipophilicity of fragments and early hits
-
Mortenson, P. N.; Murray, C. W. Assessing the lipophilicity of fragments and early hits J. Comput.-Aided Mol. Des. 2011, 25, 663-667
-
(2011)
J. Comput.-Aided Mol. Des.
, vol.25
, pp. 663-667
-
-
Mortenson, P.N.1
Murray, C.W.2
-
33
-
-
80052844344
-
Getting physical in drug discovery II: The impact of chromatographic hydrophobicity measurements and aromaticity
-
Young, R. J.; Green, D. V. S.; Luscombe, C. N.; Hill, A. P. Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity Drug Discovery Today 2011, 16, 822-830
-
(2011)
Drug Discovery Today
, vol.16
, pp. 822-830
-
-
Young, R.J.1
Green, D.V.S.2
Luscombe, C.N.3
Hill, A.P.4
-
34
-
-
0035733599
-
Ortho effect in dissociation of substituted N-phenylbenzenesulfonamides
-
DOI 10.1135/cccc20011380
-
Nadvornik, J.; Ludwig, M. Ortho effect in dissociation of substituted N -phenylbenzenesulfonamides Collect. Czech. Chem. Commun. 2001, 66, 1380-1392 (Pubitemid 33596260)
-
(2001)
Collection of Czechoslovak Chemical Communications
, vol.66
, Issue.9
, pp. 1380-1392
-
-
Nadvornik, J.1
Ludwig, M.2
-
35
-
-
77951095524
-
Oxetanes in drug discovery: Structural and synthetic insights
-
Wuitschik, G.; Carreira, E. M.; Wagner, B.; Fischer, H.; Parrilla, I.; Schuler, F.; Rogers-Evans, M.; Müller, K. Oxetanes in drug discovery: structural and synthetic insights J. Med. Chem. 2010, 53, 3227-3246
-
(2010)
J. Med. Chem.
, vol.53
, pp. 3227-3246
-
-
Wuitschik, G.1
Carreira, E.M.2
Wagner, B.3
Fischer, H.4
Parrilla, I.5
Schuler, F.6
Rogers-Evans, M.7
Müller, K.8
-
36
-
-
84859446019
-
-
Unpublished results.
-
Cahn, A.; Hodgson, S. T.; Wilson, R.; Robertson, J.; Watson, J.; Beerahee, M.; Hughes, S. C.; Young, G.; Graves, R. H.; Hall, D. A.; van Marle, S. Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a chemokine receptor 4 antagonist, in healthy subjects. Unpublished results.
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2239633, A Chemokine Receptor 4 Antagonist, in Healthy Subjects
-
-
Cahn, A.1
Hodgson, S.T.2
Wilson, R.3
Robertson, J.4
Watson, J.5
Beerahee, M.6
Hughes, S.C.7
Young, G.8
Graves, R.H.9
Hall, D.A.10
Van Marle, S.11
-
37
-
-
54349117013
-
Identification of a putative intracellular allosteric antagonist binding-site in the CXC chemokine receptors CXCR1 and CXCR2
-
Nicholls, D. J; Tomkinson, N. P.; Wiley, K. E.; Brammall, A.; Bowers, L.; Grahames, C.; Gaw, A.; Meghani, P.; Shelton, P.; Wright, T. J.; Mallinder, P. R. Identification of a putative intracellular allosteric antagonist binding-site in the CXC chemokine receptors CXCR1 and CXCR2 Mol. Pharmacol. 2008, 74, 1193-1202
-
(2008)
Mol. Pharmacol.
, vol.74
, pp. 1193-1202
-
-
Nicholls, D.J.1
Tomkinson, N.P.2
Wiley, K.E.3
Brammall, A.4
Bowers, L.5
Grahames, C.6
Gaw, A.7
Meghani, P.8
Shelton, P.9
Wright, T.J.10
Mallinder, P.R.11
-
38
-
-
84875195065
-
-
Unpublished results.
-
Slack, R. J.; Russell, L. J.; Nalesso, G.; Rumley, S. A.; Chen, Y. H.; Barnes, A.; Hall, D. A. Antagonism of human CC-chemokine receptor 4 can be achieved through three distinct binding sites on the receptor. Unpublished results.
-
Antagonism of Human CC-chemokine Receptor 4 Can Be Achieved Through Three Distinct Binding Sites on the Receptor
-
-
Slack, R.J.1
Russell, L.J.2
Nalesso, G.3
Rumley, S.A.4
Chen, Y.H.5
Barnes, A.6
Hall, D.A.7
|